Full-Time

Senior Scientist

Computational Biology

Confirmed live in the last 24 hours

Recursion Pharmaceuticals

Recursion Pharmaceuticals

501-1,000 employees

Clinical-stage biotechnology company for drug discovery

Data & Analytics

Compensation Overview

£90k - £110kAnnually

+ Bonus + Equity Compensation

Senior

London, UK

Hybrid position requiring 50% in-office presence.

Category
Computational Biology
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Python
Data Science
R
Data Analysis
Requirements
  • PhD in a relevant field (computational biology, systems biology, bioinformatics, cancer/cell biology, etc.) with a very strong computational focus and 3+ years of experience in biotech or pharma industry solving fundamental problems in oncology or drug discovery OR MS in a relevant field and 5+ years of experience in biotech or pharma industry solving fundamental problems in oncology or drug discovery
  • Experience applying computational methods (including probabilistic, statistical, and/or machine learning techniques) to analyze and integrate complex biological and/or human clinical data in a high level programming language such as Python or R
  • Experience in efficiently advancing drug programs from hit nomination through proof of concept and into clinical development (or some stages within this range)
  • Expertise in the analysis and data integration of one or more ‘omics data modalities (phenomics, transcriptomics, proteomics, genomics)
  • Exceptional data visualization skills
  • Excellent cross-functional communication skills, including an ability to explain complex scientific concepts to a variety of audiences using a combination of plots, documents, and presentations
Responsibilities
  • Design experiments, develop and scale new analysis methods, and drive key program decisions with the ultimate goal of bringing life-changing therapies to patients at unprecedented speed
  • Evaluate the molecular evidence for therapeutic hypotheses and accelerate drug program progression into the clinic, primarily in oncology
  • Architect quantitative analyses and experiment cascades that collect and combine diverse datasets to inform statistically-sound decisions at scale
  • Deliver biological insights on therapeutic candidates and disease biology that support stage gate decisions from the analysis of high dimensional (phenomics, transcriptomics, proteomics, patient-derived) datasets
  • Present data analysis to decision makers and stakeholders in a clear and compelling way that drives toward getting medicines to patients
  • Industrialize analysis approaches to not only solve for the current project, but also to accelerate future projects and scale the impact that we can have
  • Collaborate cross-functionally with Recursion’s data science, platform, ML and clinical teams to further advance Recursion’s ability to interpret and translate large-scale data assets into therapeutic programs
Recursion Pharmaceuticals

Recursion Pharmaceuticals

View

Recursion is a clinical-stage biotechnology company utilizing a synchronized combination of hardware, software, and data to industrialize drug discovery and decode complex biology, reshaping the traditional drug discovery funnel through technological innovations. Their approach integrates biology, chemistry, automation, and data science to build a next-generation biopharmaceutical company.

Company Stage

IPO

Total Funding

$764.1M

Headquarters

Salt Lake City, Utah

Founded

2013

Growth & Insights
Headcount

6 month growth

17%

1 year growth

3%

2 year growth

17%